CLINICAL_TRIALS
trial_result
· 2022-12-01
Clinical Trial Update: Project 2, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Opioid Abusers [Phase 1, Phase 2]
Summary
An early-to-mid stage trial evaluating extended exposure to low-nicotine cigarettes in individuals with tobacco use disorder has completed phase 1 and phase 2, …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Vermont | Conditions: Tobacco Use Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-12-01